Phase 1 trial of concurrent erlotinib, celecoxib, and reirradiation for recurrent head and neck cancer.
Saved in:
| Title: | Phase 1 trial of concurrent erlotinib, celecoxib, and reirradiation for recurrent head and neck cancer. |
|---|---|
| Authors: | Kao J; Department of Radiation Oncology, Mount Sinai School of Medicine, New York, New York, USA. johnnykaomd@gmail.com, Genden EM, Chen CT, Rivera M, Tong CC, Misiukiewicz K, Gupta V, Gurudutt V, Teng M, Packer SH |
| Source: | Cancer [Cancer] 2011 Jul 15; Vol. 117 (14), pp. 3173-81. Date of Electronic Publication: 2011 Jan 18. |
| Publication Type: | Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
